Participants received weekly subcutaneous injections of retatrutide at one of four doses, or placebo, for 48 weeks
This is why if someone tells me they have a 2/3-finger separation, its important, but all it really means is that I need more information
She adds that starting with a lower dose of 2 mg/week instead of 4 mg/week may help mitigate adverse effects
Interactions and underlying conditions: Concurrent medications that reduce saliva or medical conditions such as diabetes, neuropathy, or Sjgren syndrome can make dry mouth more likely while on tirzepatide
Kristy Fazzio McCoy NP Family Practice Nurse Practitioner Kristy is a board-certified nurse practitioner with dual certifications in Family Practice and Acute Care/Acute Gerontology
Realistic UK availability, first privately and then through the NHS, isnt expected until 2027 or 2028